scholarly article | Q13442814 |
P2093 | author name string | Yu Zhang | |
Jun Lu | |||
Shan Zhu | |||
Yanyan Gao | |||
Baiqu Huang | |||
Chenfei Kong | |||
Qian Liang | |||
Juan Du | |||
Guoping Zhang | |||
Dongmei Su | |||
Jianchao Zhang | |||
Shuyan Huang | |||
Zhixiong Dong | |||
P2860 | cites work | DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development | Q22010765 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | colorectal cancer | Q188874 |
apoptotic process | Q14599311 | ||
colorectal carcinoma | Q25493920 | ||
P1104 | number of pages | 11 | |
P304 | page(s) | 551-561 | |
P577 | publication date | 2011-02-01 | |
P1433 | published in | International Journal of Cancer | Q332492 |
P1476 | title | DNMT3a plays a role in switches between doxorubicin-induced senescence and apoptosis of colorectal cancer cells | |
P478 | volume | 128 |
Q38166821 | Acute myeloid leukemia with DNMT3A mutations |
Q100430027 | Angiotensin inhibition and cellular senescence in the developing rat kidney |
Q53692066 | Cellular Senescence in the Treatment of Ovarian Cancer. |
Q38760713 | DNA methylation in normal and malignant hematopoiesis |
Q34667618 | DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia |
Q27851686 | Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience. |
Q42803121 | Downregulation of methyltransferase Dnmt2 results in condition-dependent telomere shortening and senescence or apoptosis in mouse fibroblasts |
Q47666634 | Editor's Highlight: The Altered DNA Methylome of Chronic Doxorubicin Exposure in Sprague Dawley Rats |
Q54985792 | Forskolin attenuates doxorubicin-induced accumulation of asymmetric dimethylarginine and s-adenosylhomocysteine via methyltransferase activity in leukemic monocytes. |
Q92246769 | Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3 |
Q57030083 | Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies |
Q37569819 | Induction of Epigenetic Alteration by CPUK02, An Ent- kaurenoid Derivative of Stevioside. |
Q39003476 | Inhibition enhancer of zeste homologue 2 promotes senescence and apoptosis induced by doxorubicin in p53 mutant gastric cancer cells |
Q90011561 | Integrative Clustering Reveals a Novel Subtype of Soft Tissue Sarcoma With Poor Prognosis |
Q41502851 | Reduced levels of methyltransferase DNMT2 sensitize human fibroblasts to oxidative stress and DNA damage that is accompanied by changes in proliferation-related miRNA expression. |
Q90393831 | Role of p53 in the Regulation of Cellular Senescence |
Q38582491 | Role of the nucleus in apoptosis: signaling and execution |
Q35606946 | SOX7 is involved in aspirin-mediated growth inhibition of human colorectal cancer cells |
Q59295183 | Screening for mutation R882 in the DNMT3A gene in Chinese patients with hematological disease |
Q34619554 | Senescence and apoptosis: dueling or complementary cell fates? |
Q39449103 | Senescent cells: an emerging target for diseases of ageing |
Q89835065 | The Histone Code of Senescence |
Q48206152 | Therapeutic doses of doxorubicin induce premature senescence of human mesenchymal stem cells derived from menstrual blood, bone marrow and adipose tissue |
Q39095982 | miR-194 functions as a novel modulator of cellular senescence in mouse embryonic fibroblasts |
Search more.